logo
Global Defense Contractor Burke Products Selects Datavault AI for Enhanced National Defense and Aerospace Technologies Contracts

Global Defense Contractor Burke Products Selects Datavault AI for Enhanced National Defense and Aerospace Technologies Contracts

Austin, Texas, United States, July 22nd, 2025, FinanceWire
Datavault AI Selected to Support Mission-Critical Defense and Aerospace Programs in Strategic Partnership with Burke Engineering
Datavault AI Inc. (NASDAQ: DVLT), a leader in data visualization, valuation, and monetization technologies, today announced a strategic partnership with Burke Products ('Burke'), a minority-owned Tier 1 supplier to Lockheed Martin, Raytheon Technologies, Department of Defense, Original Equipment Manufacturers (OEMs), and the Defense Logistics Agency as well as their international allied force corollaries. The partnership stands to deliver 2025 Revenues from existing contracts of Burke's that have now been subcontracted to Datavault AI and is set to scale into productized offerings into 2026.
Within the partnership Datavault AI has been contracted by Burke Products to engineer and produce solutions responsive to an array of opportunities. All opportunities are managed under the contract in a case by case fashion designed to be responsive to private and public RFPs and requests made directly and through subcontracts obtained by Burke and other contracting mechanisms in place at Burke Products on a global basis.
Military grade engineering, manufacturing and productization is now underway. The collaboration aims to advance defense and aerospace capabilities by integrating Datavault AI's services and proprietary data and ADIO® tone technologies with Burke's experienced manufacturing and engineering teams to accelerate productization and speed to market that Datavault AI's technologies have been designed to automate and support at scale.
According to Janes, global defense spending is projected to exceed $2.2 trillion in 2025, with the U.S. defense budget alone expected to surpass $900 billion. As modernization efforts escalate, the sector is increasingly focused on secure data solutions, advanced tracking, and predictive intelligence—areas where Datavault AI is uniquely positioned to deliver for Burke new and innovative solutions that solve for advantages and forward progression of technologies in this sector. With Web 3.0 centric contributions of Datavault AI this partnership will explore technological synergies with particular emphasis on secure data management, resource tracking, and communication systems critical to mission success.
Aaron Bakhshi, CEO of Burke Products, shared his outlook on the business alliance and licensing contracts now in place with Datavault AI, 'For more than 59 years, Burke Products has supplied advanced electro-mechanical components and assemblies to leading defense and aerospace partners, including Lockheed Martin, Raytheon Technologies, Northrop Grumman, General Dynamics, the U.S. Navy, the Defense Logistics Agency, and their allied international counterparts. As a minority-owned defense contractor committed to engineering innovation, we view this strategic alliance with Datavault AI as a transformative step toward future-ready solutions. The introduction and demonstrations of Datavault's solutions into our product portfolio marks a significant evolution in how we approach innovation across mission-critical systems.'
Bakhshi continued: 'This collaboration originated from Sonia Choi's ability to identify and align mutual strategic interests, particularly around innovations in acoustic sciences and separately, the urgent challenge of addressing stolen valor—two distinct areas where Datavault AI's platform provides an elegant and effective solution. Additionally, our shared vision around the scalable deployment of Digital Twin technologies further strengthens the foundation of this partnership and unlocks significant future potential. Her skill in connecting advanced technology to real-world defense applications and viable business models was instrumental in forming this agreement. It resonates with me, as it reflects the executive vision and innovation that Burke Products strives to champion across all of our initiatives. We believe the work underway with Datavault AI will deliver measurable value to our clients and help redefine operational standards across multiple defense verticals with new Web 3.0 solutions.'
The first phase will integrate Datavault AI's acoustic sciences services and products, including patented ADIO® tone technology, into Burke's pre-existing systems. Future phases may expand into integrating Datavault AI's proprietary data solutions for digital twin modeling, predictive analytics, inventory logistics and management as well as blockchain-based tools to secure supply chains and authenticate critical components throughout their lifecycle.
'It has been an honor to work with and partner alongside Aaron Bakhshi and Burke Products to help extend Datavault AI's orchestrated blend of talent and technological footprint into the defense sector,' said Sonia Choi, Co-Founder and CMO of Datavault AI and Lead Principal Investigator on a privately funded Strategic Partnership Project facilitated through the U.S. Department of Energy's Brookhaven National Laboratory.
'Burke Products has a rare and profound legacy of combining engineering precision with innovation—qualities that immediately resonated with our shared commitment to mission-critical performance. We are both builders and systems thinkers, capable of harnessing our technologies to automate high-value solutions in environments defined by complexity and zero tolerance for error. By leveraging our advanced data and acoustic sciences to solve real-world problems and by aligning our ecosystems together, we're laying the groundwork for scalable, American-built solutions. This marks a pivotal step and underscores Datavault AI's strategic entry into, and sustained relevance within, modern defense infrastructure,' stated Sonia Choi.
As the defense and aerospace sectors rapidly evolve, this partnership marks a significant milestone. With a focus on security, precision, and next-gen data integration, Datavault AI and Burke Products are working together to shape the future of national defense technology.
Nathaniel T. Bradley, Co-Founder and CEO of Datavault AI, asserted: ' This collaboration marks an international milestone of a scale we couldn't have anticipated when we first founded the company. Sonia Choi has been diligently building toward this moment for years, and her ability to identify high-impact applications for Datavault AI's technologies—while guiding our team through the execution with focus and discipline—has been exceptional. Through her vision and leadership, we've reached a breakthrough that aligns seamlessly across our VerifyU, ADIO®, High Performance Computing, WiSA and Datavault platforms, in concert with Burke Products' expansive capabilities, trusted network, and precision-driven engineering excellence.'
Bradley noted, 'Together, with Burke Products, we now have an industry leading, solutions-oriented contracting partner that not only understands Datavault AI's mission, but is equipped to deliver defense-grade, purpose-built innovations when they are most needed. Sonia's and Aaron's influence will have a lasting impact—not only on Datavault AI's trajectory, but on the broader U.S. defense industry it serves. We're deeply grateful to Burke Products for validating our intellectual property, recognizing the strength of our team, and stepping forward with us to realize the full potential of this partnership.'
About Datavault AI Inc.
Datavault AITM (Nasdaq: DVLT) is leading the way in AI driven data experiences, valuation and monetization of assets in the Web 3.0 environment. The company's cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Science and Data Science Divisions. Datavault AI's Acoustic Science Division features WiSA®, ADIO® and Sumerian® patented technologies and industry-first foundational spatial and multichannel wireless HD sound transmission technologies with IP covering audio timing, synchronization and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. Datavault AI's cloud-based platform provides comprehensive solutions serving multiple industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange® (IDE) enables Digital Twins, licensing of name, image and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity. Datavault AI's technology suite is completely customizable and offers AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The company is headquartered in Beaverton, OR. Learn more about Datavault AI at www.dvlt.ai.
About Burke Products, Inc.
Burke Products, Inc. is a minority-owned manufacturer of high-precision electro-mechanical components and assemblies, serving the aerospace and defense sectors for over 59 years. The company has established a longstanding reputation for reliability and excellence across critical supply chains, maintaining established relationships with clients including the U.S. Department of Defense, Defense Logistics Agency (DLA), Lockheed Martin, Raytheon Technologies, Honeywell, General Dynamics, Goodrich, and Johnson & Johnson. Internationally, Burke has fulfilled government contracts and procurement programs for India and our allied defense partners in the UK, Japan, Germany, Turkey, and many others. Operating under ISO and AS-compliant quality systems, Burke specializes in contracted manufacturing, acoustic systems and technology integration, and rapid design-to-production capabilities for defense-grade hardware. Its core competencies support both domestic and allied military readiness through scalable, high-integrity supply partnerships.
To learn more about Burke Products, please visit https://burkeproducts.com/.
Cautionary Note Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and other securities laws. Words such as "expect," "will," "anticipates," "estimates" and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Such forward-looking statements, including statements herein regarding our business opportunities and prospects, strategy, future revenue expectations, licensing initiatives, recent funding and M&A activities as well as our plans to integrate acquired businesses and technologies, are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various risks and uncertainties including, but not limited to, the following: the risk that we are unable to satisfy all closing conditions in connection with the senior notes issuance described above, and the acquisition of certain assets from CSI; our ability to successfully integrate all IP that we have acquired; risks regarding our ability to utilize the assets we acquire to successfully grow our market share; risks regarding our ability to open up new revenue streams as a result of the various agreements we have entered into and assets we have acquired; our current liquidity position and the need to obtain additional financing to support ongoing operations; general market, economic and other conditions; our ability to continue as a going concern; our ability to maintain the listing of our common stock on Nasdaq; our ability to manage costs and execute on our operational and budget plans; our ability to achieve our financial goals; the degree to which our licensees implement the licensed technology into their products, if at all; the timeline to any such implementation; risks related to technology innovation and intellectual property, and other risks as more fully described in our filings with the U.S. Securities and Exchange Commission. The information in this press release is provided only as of the date of this press release, and we undertake no obligation to update any forward-looking statements contained in this communication based on new information, future events, or otherwise, except as required by law.
Marketing Inquiries:
marketing@vault.email
Contact
IBN
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

MRNA Earnings: Moderna Stock Slumps 10% on Lower Covid Vaccine Demand
MRNA Earnings: Moderna Stock Slumps 10% on Lower Covid Vaccine Demand

Business Insider

time10 hours ago

  • Business Insider

MRNA Earnings: Moderna Stock Slumps 10% on Lower Covid Vaccine Demand

Shares in drug giant Moderna (MRNA) plummeted nearly 10% today after it reported a drop in Q2 sales. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The company reported earnings for the period of -$2.13, beating expectations of -$3.03 but also recorded a 41.1% drop in year-over-year sales to $142 million. However, that still beat forecasts of $128.3 million. Sentiment Hit Investor sentiment was also hit by the company dropping its revenue guidance for the full year to $1.85 billion at the midpoint from $2 billion, a 7.5% decrease. It blamed the 'timing of shipments.' The decline was primarily driven by lower Spikevax COVID vaccine sales, which totaled $114 million in the quarter. Moderna said demand is expected to be concentrated in the second half of the year, aligning with the fall and winter seasons as the vaccine continues to transition into a seasonal respiratory product. It also reported 'negligible' RSV vaccine mRESVIA® sales in the second quarter of 2025. The figures continue Moderna's difficult year in comparison with its peers – see below. 'In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine efficacy data and expanded our commercial portfolio with three new U.S. FDA approvals to drive future sales growth,' said Stéphane Bancel, Chief Executive Officer of Moderna. 'Looking forward, we have important catalysts over the next six months across our infectious disease and oncology programs that will help us deliver on the promise of our mRNA platform for patients.' Future Hopes This includes Intismeran autogene, a personalized cancer therapy which is being developed in collaboration with Merck (MRK). This includes two non-small cell lung cancer Phase 3 studies and Phase 2 studies for high-risk muscle invasive and high-risk non-muscle invasive bladder cancer. Cost of sales for 2025 is expected to be approximately $1.2 billion. Full-year 2025 research and development expenses are anticipated to be $3.6 to $3.8 billion, lowered from previous expectations of approximately $4.1 billion. Year-end cash and investments for 2025 are projected to be approximately $6 billion. Recently, Moderna announced an organizational restructuring that will reduce its global workforce by approximately 10%. The company anticipates a total headcount of less than 5,000 by the end of the year. Better news came today for the group after Pfizer (PFE) and its German partner BioNTech (BNTX) lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents at London's Court of Appeal.

Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align's Common Stock
Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align's Common Stock

Business Wire

time16 hours ago

  • Business Wire

Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align's Common Stock

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. ('Align') (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Joe Hogan, Align Technology president and CEO, has personally purchased approximately $1 million of Align's common stock. Since his last sale of Align common stock in 2021, Mr. Hogan has purchased approximately $8 million of Align common stock 1. 'This purchase reflects my continuing confidence in the long-term value of Align and our commitment to increasing shareholder value by balancing investments to drive growth and continuing to invest with discipline in the areas that will define our future,' said Joe Hogan, president and CEO. 'We are excited about our next-generation technologies and treatment platforms that meet today's patient expectations for fast, effective, and personalized treatment while also providing value and growth opportunities for our doctor customers. We believe that these innovations are not only improving outcomes in Invisalign practices but also expanding our addressable market and strengthening our competitive differentiation.' Continued Hogan, 'While we believe that the macroeconomic uncertainty will likely persist into the near future, we are confident in our ability to adapt and lead. Our long-term strategic initiatives and opportunities remain intact, as does our commitment to focused execution on transforming treatment for doctors and patients.' 1 Valued based on the purchase price of Align common stock at the time of each purchase. About Align Technology Align Technology designs and manufactures the Invisalign ® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 286.4 thousand doctor customers and are key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.8 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit for more information. For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit For additional information about the iTero digital scanning system, please visit For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit Invisalign, iTero, exocad, Align, Align Digital Platform, and iTero Lumina are trademarks of Align Technology, Inc.

KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

time18 hours ago

  • Business Wire

KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MAHWAH, N.J.--(BUSINESS WIRE)-- KORU Medical Systems, Inc. (NASDAQ: KRMD) ('KORU Medical' or the 'Company'), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced inducement equity awards to Adam Kalbermatten, Chief Commercial Officer, pursuant to his previously announced employment agreement with the Company dated as of June 30, 2025. Mr. Kalbermatten was granted nonqualified stock options on August 1, 2025 to purchase 600,000 shares of the Company's common stock at an exercise price of $3.44 per share. In addition, on July 28, 2025, his start date, Mr. Kalbermatten received 300,000 restricted shares of the Company's common stock. Each of these awards are subject to vesting 25% on each anniversary of their grant date, subject to accelerated vesting and the other terms and conditions of the respective award agreements entered into between Mr. Kalbermatten and the Company. The Compensation Committee of the Company's Board of Directors approved the awards as an inducement material to Mr. Kalbermatten's employment in accordance with Nasdaq Listing Rule 5635(c)(4). About KORU Medical Systems KORU Medical Systems develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The Freedom Syringe Infusion System (the 'Freedom System') currently includes the Freedom60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HigH-Flo Subcutaneous Safety Needle Sets™. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by the patient and/or delivery in an ambulatory infusion center by a healthcare professional. Through its Pharma Services and Clinical Trials business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of customizing the Freedom System for clinical and commercial use across multiple drug categories. For more information, please visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store